JPXN:NYE-iShares JPX-Nikkei 400 ETF (USD)

ETF | Japan Stock |

Last Closing

USD 75.93

Change

-0.23 (-0.30)%

Market Cap

N/A

Volume

1.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

-0.09 (-0.30%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

-0.03 (-0.04%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

-0.08 (-0.27%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

-0.37 (-0.46%)

N/A
DXJ WisdomTree Japan Hedged Equity..

-0.21 (-0.19%)

N/A
EWJ iShares MSCI Japan ETF

-0.28 (-0.39%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.17 (-0.42%)

N/A
HEWJ iShares Currency Hedged MSCI J..

-0.04 (-0.10%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

+0.06 (+0.08%)

N/A

ETFs Containing JPXN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.67% 60% D- 62% D
Dividend Return 0.87% 40% F 15% F
Total Return 12.54% 60% D- 57% F
Trailing 12 Months  
Capital Gain 20.55% 70% C- 54% F
Dividend Return 2.99% 70% C- 41% F
Total Return 23.53% 70% C- 52% F
Trailing 5 Years  
Capital Gain 24.64% 50% F 58% F
Dividend Return 6.76% 30% F 20% F
Total Return 31.40% 40% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 4.99% N/A N/A 55% F
Dividend Return 6.27% N/A N/A 51% F
Total Return 1.29% N/A N/A 30% F
Risk Return Profile  
Volatility (Standard Deviation) 18.20% N/A N/A 56% F
Risk Adjusted Return 34.48% N/A N/A 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike